Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...

Fintel reports that on March 12, 2025, William Blair downgraded their outlook for Udemy (NasdaqGS:UDMY) from Outperform to ...

Equities researchers at William Blair lowered their Q1 2025 EPS estimates for WillScot Mobile Mini in a report issued on Monday, March 10th. William Blair analyst T. Mulrooney now forecasts that the ...

Fintel reports that on March 11, 2025, William Blair upgraded their outlook for Genmab A (NasdaqGS:GMAB) from Market Perform ...

The embedded finance company, which posted a loss last year, hired Citi to explore its strategic options and named an interim ...

The note emphasized that Palantir shares declined 10% following a 4% selloff in the Nasdaq, and if the broader market ...

JPMorgan Chase & Co. has hired William Kallop from William Blair & Co. for its mergers and acquisitions group focused on ...

The firm upgraded Palantir from Underperform to Market Perform after a sharp stock decline but did not assign a price target.

William Blair Large Cap Growth Fund earns an Average Process Pillar rating. The main contributor to the rating is the stability of the management team. Specifically, the fund has not seen a ...

CMS approves ADLT status for Guardant Health's Shield test, setting Medicare reimbursement at $1,495. The analyst sees a ...